Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Dr. Reddy's Laboratories Ltd.
NSE: DRREDDY
|
BSE: 500124
|
ISIN: INE089A01031
|
Industry: Pharmaceuticals
US FDA Observation
|
Mid-range Performer
1280.0000
8.00
(
0.63
%)
NSE
Dec 18, 2025
15:31 PM
25.49% Gain from 52W Low
Volume:
889.7K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Dr. Reddy's Laboratories Ltd.
11 May 2023
US FDA Observation
1280.00
0.63%
Dr Reddy's Labs (HOLD): Core business remains sluggish
Hold:
Dr. Reddy's Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 4900
Target
BOB Capital Markets Ltd.
Q4 broadly in line as revenue/EBITDA grew 16%/35% YoY (-7%/-23% QoQ), albeit aided by one-offs
Dr. Reddy's Laboratories Ltd. is trading above all available SMAs
More from Dr. Reddy's Laboratories Ltd.
Recommended
Market closes flat as gains in financials & IT stocks offset losses in other sectors
Trendlyne Marketwatch |
18 Dec 2025, 04:19PM
Global aviation is growing, but competition is not
The Baseline |
18 Dec 2025, 01:35PM
Dr Reddy’s Labs struggles in its biggest market
|
18 Aug 2021, 11:13AM